Small molecule inhibitors, such as BI‐69A11, can inhibit all three isoforms of AKT and suppress the cell viability of melanoma with NRAS mutation in vitro and the growth of xenografts tumor models [235, 236]. This evidence concerns the gene AKT1 and melanoma.